NCT00861510 2019-12-03A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed16 enrolled